INC.;SLOAN-KETTERING INSTITUTE FOR CANCER RESEARCH;ARAGON PHARMACEUTICALS, INC.;ARAGON PHARMACEUTICALS
发明人:
SMITH, NICHOLAS, D.,HERBERT, MARK, R.,OUERFELLI, OUATHEK,DILHAS, ANNA
申请号：
EP13800681
公开号：
EP2858985A4
申请日:
2013.06.04
申请国别(地区):
EP
年份:
2016
代理人:
摘要：
Described herein are crystalline forms of the androgen receptor modulated 4-[7-(6-cyano-5-trifluoromethylpyridin-3-yl)-8-oxo-6-thioxo-5,7-diazaspiro[3,4]oct-5-yl]-2-fluoro-N-methylbenzamide, pharmaceutically acceptable salts, solvates, as well as pharmaceutical compositions thereof, and the same for use in treatment or prevention of diseases or conditions associated with androgen receptor activity.
